135 related articles for article (PubMed ID: 9160270)
1. An improved method for the simultaneous determination of losartan and its major metabolite, EXP3174, in human plasma and urine by high-performance liquid chromatography with fluorescence detection.
Ritter MA; Furtek CI; Lo MW
J Pharm Biomed Anal; 1997 Apr; 15(7):1021-9. PubMed ID: 9160270
[No Abstract] [Full Text] [Related]
2. Simultaneous determination of losartan and EXP3174 in human plasma and urine utilizing liquid chromatography/tandem mass spectrometry.
Polinko M; Riffel K; Song H; Lo MW
J Pharm Biomed Anal; 2003 Sep; 33(1):73-84. PubMed ID: 12946533
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of a novel angiotensin II receptor blocking agent, losartan, and its metabolite in human plasma and urine by high-performance liquid chromatography.
Furtek CI; Lo MW
J Chromatogr; 1992 Jan; 573(2):295-301. PubMed ID: 1601963
[TBL] [Abstract][Full Text] [Related]
4. Simple high-performance liquid chromatographic method for determination of losartan and E-3174 metabolite in human plasma, urine and dialysate.
Farthing D; Sica D; Fakhry I; Pedro A; Gehr TW
J Chromatogr B Biomed Sci Appl; 1997 Dec; 704(1-2):374-8. PubMed ID: 9518174
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of a new potent angiotensin II receptor antagonist, TCV-116, and its metabolites in human serum and urine.
Miyabayashi T; Okuda T; Motohashi M; Izawa K; Yashiki T
J Chromatogr B Biomed Appl; 1996 Feb; 677(1):123-32. PubMed ID: 8925084
[TBL] [Abstract][Full Text] [Related]
6. HPLC assays to simultaneously determine the angiotensin-AT1 antagonist losartan as well as its main and active metabolite EXP 3174 in biological material of humans and rats.
Soldner A; Spahn-Langguth H; Mutschler E
J Pharm Biomed Anal; 1998 Jan; 16(5):863-73. PubMed ID: 9535198
[TBL] [Abstract][Full Text] [Related]
7. Comparison of liquid chromatography, capillary electrophoresis and super-critical fluid chromatography in the determination of Losartan Potassium drug substance in Cozaar tablets.
Williams RC; Alasandro MS; Fasone VL; Boucher RJ; Edwards JF
J Pharm Biomed Anal; 1996 Aug; 14(11):1539-46. PubMed ID: 8877861
[TBL] [Abstract][Full Text] [Related]
8. Determination of candesartan cilexetil, candesartan and a metabolite in human plasma and urine by liquid chromatography and fluorometric detection.
Stenhoff H; Lagerström PO; Andersen C
J Chromatogr B Biomed Sci Appl; 1999 Aug; 731(2):411-7. PubMed ID: 10510797
[TBL] [Abstract][Full Text] [Related]
9. Separation and quantitation of several angiotensin II receptor antagonist drugs in human urine by a SPE-HPLC-DAD method.
Ferreirós N; Iriarte G; Alonso RM; Jiménez RM; Ortíz E
J Sep Sci; 2008 Mar; 31(4):667-76. PubMed ID: 18307163
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans.
Ohtawa M; Takayama F; Saitoh K; Yoshinaga T; Nakashima M
Br J Clin Pharmacol; 1993 Mar; 35(3):290-7. PubMed ID: 8471405
[TBL] [Abstract][Full Text] [Related]
11. pK(a) determination of angiotensin II receptor antagonists (ARA II) by spectrofluorimetry.
Cagigal E; González L; Alonso RM; Jiménez RM
J Pharm Biomed Anal; 2001 Oct; 26(3):477-86. PubMed ID: 11489393
[TBL] [Abstract][Full Text] [Related]
12. High-performance liquid chromatographic determination of angiotensin II receptor antagonists in human plasma and urine. I. DuP 532 (L-694,492).
Chiou RH; Lo MW
J Chromatogr; 1992 Oct; 581(1):165-70. PubMed ID: 1430003
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin.
Morsing P; Adler G; Brandt-Eliasson U; Karp L; Ohlson K; Renberg L; Sjöquist PO; Abrahamsson T
Hypertension; 1999 Jun; 33(6):1406-13. PubMed ID: 10373224
[TBL] [Abstract][Full Text] [Related]
14. Determination of plasma concentrations of losartan in patients by HPLC using solid phase extraction and UV detection.
Yeung PK; Jamieson A; Smith GJ; Fice D; Pollak PT
Int J Pharm; 2000 Aug; 204(1-2):17-22. PubMed ID: 11011981
[TBL] [Abstract][Full Text] [Related]
15. Nonpeptide angiotensin II receptor antagonist: pharmacokinetics and pharmacodynamics in rats of EXP3174, an active metabolite of losartan.
Wong PC; Christ DD; Wong YN; Lam GN
Pharmacology; 1996 Jan; 52(1):25-9. PubMed ID: 8966199
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous quantitative determination of olmesartan and hydrochlorothiazide in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry.
Liu D; Jiang J; Wang P; Feng S; Hu P
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(9-10):743-8. PubMed ID: 20153270
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans.
Lo MW; Goldberg MR; McCrea JB; Lu H; Furtek CI; Bjornsson TD
Clin Pharmacol Ther; 1995 Dec; 58(6):641-9. PubMed ID: 8529329
[TBL] [Abstract][Full Text] [Related]
18. Pre-treatment with curcumin enhances plasma concentrations of losartan and its metabolite EXP3174 in rats.
Liu AC; Zhao LX; Xing J; Liu T; Du FY; Lou HX
Biol Pharm Bull; 2012; 35(2):145-50. PubMed ID: 22293343
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of column-switching high-performance liquid chromatographic methods for the determination of a potent AII receptor antagonist, TCV-116, and its metabolites in human serum and urine.
Lee JW; Naidong W; Johnson T; Dzerk A; Miyabayashi T; Motohashi M
J Chromatogr B Biomed Appl; 1995 Aug; 670(2):287-98. PubMed ID: 8548019
[TBL] [Abstract][Full Text] [Related]
20. Method for the simultaneous determination of losartan and its major metabolite, EXP-3174, in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry.
Iwasa T; Takano T; Hara K; Kamei T
J Chromatogr B Biomed Sci Appl; 1999 Nov; 734(2):325-30. PubMed ID: 10595730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
